Nitric oxide, cAMP and the biphasic muscarinic modulation of ACh release at the lizard neuromuscular junction

Journal of Physiology

Volumn 559, Issue 2, 2004, Pages 423-432

  Graves, Austin R ^a   Lewin, Katherine A ^a   Lindgren, Clark A ^a  

^a GRINNELL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; NITRIC OXIDE; MUSCARINE; NITRIC OXIDE SYNTHASE;

ACETYLCHOLINE BRAIN LEVEL; ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; LIZARD; NEUROMODULATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SYNAPTIC TRANSMISSION; ANOLIS CAROLINENSIS; ENDPLATE POTENTIAL; FACILITATION;

ACETYLCHOLINE; ANIMALS; CYCLIC AMP; LIZARDS; MUSCARINE; NEUROMUSCULAR JUNCTION; NITRIC OXIDE; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M3;

EID: 4644285199     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.064469     Document Type: Article

References (42)

1. Bourque MJ & Robitaille R (1998). Endogenous peptidergic modulation of perisynaptic Schwann cells at the frog neuromuscular junction. J Physiol 512, 197-209.
2. Burette A, Zabel U, Weinberg RJ, Schmidt HHW & Valtschanoff JG (2002). Synaptic localization of nitric oxide synthase and soluable guanylyl cyclase in the hippocampus. J Neurosci 22, 8961-8970.
3. Castonguay A, Lévesque S & Robitaille R (2001). Glial cells as active partners in synaptic function. Prog Brain Res 132, 227-240.
4. Caulfield MP (1993). Muscarinic receptors - characterization, coupling and function. J Pharmacol Exp Ther 58, 319-379.
5. i proteins and decreased agonist affinity at M2 muscarinic acetylcholine receptors by spermine and methoctramine. Br J Pharm 127, 1021-1029.
6. D'Agostino G, Bolognesi ML, Lucchelli A, Vicini D, Balestra B, Spelta V, Melchiorre C & Tonini M (2000). Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype. Br J Pharmacol 129, 493-500.
7. 2+ channels induced by nitric oxide in human neuroblastoma IMR32 cells. J Neurosci 22, 7485-7492.
8. Del Castillo J & Katz B (1954). Quantal components of the end-plate potential. J Physiol 124, 560-573.
9. Descarries LM, Cai S & Robitaille R (1998). Localization and characterization of nitric oxide synthase at the frog neuromuscular junction. J Neurocytol 27, 829-840.
10. Duncan CJ & Publicover SJ (1979). Inhibitory effects of cholinergic agents on the release of transmitter at the frog neuromuscular junction. J Physiol 294, 91-103.
11. Felder CC (1995). Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 9, 619-625.
12. Ganguly DK & Das M (1979). Effects of oxotremorine demonstrate presynaptic muscarinic and dopaminergic receptors on motor nerve terminals. Nature 278, 645-646.
13. Georgiou J, Robitaille R, Trimble WS & Charlton MP (1994). Synaptic regulation of glial protein expression in vivo. Neuron 12, 443-455.
14. Goldberg AL & Singer JJ (1969). Evidence for a role of Cyclic AMP neuromuscular transmission. Proc Natl Acad Sci 64, 134-141.
15. Hirsh JK & Silinsky EM (2002). Inhibition of spontaneous acetylcholine secretion by 2-chloroadenosine as revealed by a protein kinase inhibitor at the mouse neuromuscular junction. Br J Pharm 135, 1897-1902.
16. Hirsh JK, Silinsky EM & Solsona CS (1990). The role of cyclic AMP and its protein kinase in mediating acetylcholine release and the action of adenosine at frog motor nerve endings. Br J Pharm 101, 311-318.
17. 3 receptors in the rat neostriatum. Neurosci Lett 197, 141-144.
18. Jahromi BS, Robitaille R & Charlton MP (1992). Transmitter release increases intracellular calcium in perisynaptic Schwann cells in situ. Neuron 8, 1069-1077.
19. Katz B & Miledi R (1977). Suppression of transmitter release at the neuromuscular junction. Proc Roy Soc Lond 196, 465-469.
20. Kuba K, Kato E, Kumamoto E, Koketsu K & Hirai K (1981). Sustained potentiation of transmitter release by adrenaline and dibutyryl cyclic AMP in sympathetic ganglia. Nature 291, 654-656.
21. Lindgren CA, Emery DG & Haydon PG (1997). Intracellular acidification reversibly reduces endocytosis at the neuromuscular junction. J Neurosci 17, 3074-3084.
22. Lindgren CA, Graves AR & Lake B (2003). Nitric Oxide is necessary but not sufficient for the biphasic muscarinic modulation of synaptic transmission at the lizard neuromuscular junction. Soc Neurosci Abstr 29, 168.11.
23. Lindgren CA & Laird MV (1994). Nitroprusside inhibits neurotransmitter release at the frog neuromuscular junction. Neuro Report 5, 2205-2208.
24. Lindgren CA & Moore JW (1989). Identification of ionic currents at presynaptic nerve endings of the lizard. J Physiol 414, 201-222.
25. Lindgren CA & Young KM (2002). The inhibition of ACh release by muscarinic agonists at the neuromuscular junction requires nitric oxide synthesis. Soc Neurosci Abstr 28, 838.3.
26. 2+ influx. J Neurosci 16, 1702-1709.
27. Michaelson DM, Avissar S, Kloog Y & Sokolovsky M (1979). Mechanism of acetylcholine release: possible involvement of presynaptic muscarinic receptors in regulation of acetylcholine release and protein phosphorylation. Proc Natl Acad Sci 76, 6336-6340.
28. Minic J, Molgó J, Karlsson E & Krejci E (2002). Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase. Eur J Neurosci 15, 439-448.
29. 2+ influx and protein kinase G. J Physiol 493, 769-784.
30. Parnas H, Segel L & Parnas I (2000). Autoreceptors, membrane potential and the regulation of transmitter release. Trends Neurosci 23, 60-68.
31. Pinard A, Lévesque S, Vallée J & Robitaille R (2003). Glutamatergic modulation of synaptic plasticity at a PNS vertebrate cholinergic synapse. Eur J Neurosci 18, 3241-3250.
32. Prast H, Tran MH, Fischer H & Philippu A (1998). Nitric oxide-induced release of acetylcholine in the nucleus accumbens: role of cyclic GMP, glutamate, and GABA. J Neurochem 71, 266-273.
33. Prothero LS, Mathie A & Richards CD (2000). Purinergic and muscarinic receptor activation activates a common calcium entry pathway in rat neocortical neurons and glial cells. J Neuropharm 39, 1768-1778.
34. Robitaille R (1998). Modulation of synaptic efficacy and synaptic depression by glial cells at the frog neuromuscular junction. Neuron 21, 847-855.
35. Rouse ST, Gilmor ML & Levey AI (1998). Differential presynaptic amd postsynaptic expression of M1-M4 muscarinic acetylcholine recepors at the perforant pathway/granule cell synapse. J Neurosci 86, 221-232.
36. Slutsky I, Parnas H & Parnas I (1999). Presynaptic effects of muscarine on ACh release at the frog neuromuscular junction. J Physiol 514, 769-782.
37. 2 muscarinic receptors are involved in controlling the kinetics of ACh release at the frog neuromuscular junction. J Physiol 536, 717-725.
38. Standaert FG (1982). Release of transmitter at the neuromuscular junction. Br J Anaesth 54, 131-145.
39. Wali FA, Suer AH, McAteer E, Dark CH & Jones CJ (1988). Effects of atropine and glycopyrrolate on neuromuscular transmission in the rat phrenic nerve-diaphragm preparation. Gen Pharm 19, 285-290.
40. Wenzel B, Elsner N & Heinrich R (2002). mAChRs in the grasshopper brain mediate excitation by activation of the AC/PKA and the PLC second-messenger pathways. J Neurophysiol 87, 876-888.
41. Wong DL, Anderson LJ & Tai TC (2002). Cholinergic and peptidergic regulation of phenylethanolamine N-methyltransferase gene expression. Ann N Y Acad Sci 971, 19-26.
42. Zhao Q, Tao J, Zhu Q, Jia PM, Dou AX, Li X, Cheng F, Waxman S, Chen GQ, Chen SJ, Lanotte M, Chen Z & Tong JH (2004). Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation. Leukemia 18, 285-292.